ArticleAnnals of hematology2025

Clinical outcome and immunophenotype of axicabtagene ciloleucel (axi-cel) and relmacabtagene autoleucel (relma-cel) in relapsed/refractory large B-Cell lymphoma on Chinese population: a single-center experience.

Danqing Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.